InMed Pharmaceuticals (INM) vs KALA BIO (KALA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.3 million vs $5.7 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | INM | KALA |
|---|---|---|
| Share price | $1.33 | $0.2966 |
| Market cap | $7.31M | $5.74M |
| 1-day change | 0.00% | -17.61% |
| EPS (TTM) | $-2.84 | $-10.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.44 | $95.50 |
| 52-week low | $0.575 | $0.2915 |
| Distance from 52-week high | -45.49% | -99.69% |
| Average volume | 914.01K | 1.45M |
| Shares outstanding | 5.49M | 19.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
INM vs KALA FAQ
Which is bigger, InMed Pharmaceuticals or KALA BIO?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.31M compared with $5.74M for KALA BIO (KALA).
Are InMed Pharmaceuticals and KALA BIO in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.